» Articles » PMID: 24843502

Utility of Indices Using C-peptide Levels for Indication of Insulin Therapy to Achieve Good Glycemic Control in Japanese Patients with Type 2 Diabetes

Overview
Specialty Endocrinology
Date 2014 May 21
PMID 24843502
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Aims/Introduction:  Type 2 diabetes is progressive in that therapy must be altered over time, which is partly as a result of the progressive loss of pancreatic β-cell function. To elucidate the relationship between residual endogenous insulin secretion and the necessity of insulin therapy to achieve good glycemic control, indices using serum C-peptide immunoreactivity (CPR) were analyzed in patients with type 2 diabetes.

Materials And Methods:   The data of 201 Japanese patients with type 2 diabetes who achieved the target of glycemic control during admission were analyzed retrospectively. Indices using CPR including fasting CPR (FCPR), CPR 6 min after intravenous injection of glucagon (CPR-6 min), increment of CPR (ΔCPR), secretory unit of islet in transplantation index (SUIT) and C-peptide index (CPI) were compared between the group requiring insulin (insulin group) and the group not requiring insulin (non-insulin group). A receiver-operator characteristic (ROC) curve was made, and optimal cut-off point and likelihood ratio were determined for each index.

Results:   All indices of CPR were lower in the insulin group compared with those in the non-insulin group. Likelihood ratios at the optimal point of FCPR, CPR-6 min, ΔCPR, SUIT, and CPI were 2.0, 2.1, 1.6, 2.3 and 2.8, respectively. Optimal cut-off point of CPI was 1.1 ng/mg. Sensitivity and specificity at optimal point of CPI were 61 and 78%, respectively.

Conclusions:   The advantage of CPI of the indices of CPR to select insulin therapy to achieve good glycemic control was shown, but limitations of the predictive abilities of the indices using CPR should be taken into account. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2010.00096.x, 2011).

Citing Articles

Effects of laparoscopic sleeve gastrectomy on weight loss and metabolic improvement in subjects aged 65 years or older: a subanalysis of J-SMART study.

Watanabe Y, Yamaguchi T, Sasaki A, Naitoh T, Matsubara H, Yokote K Diabetol Int. 2025; 16(1):56-64.

PMID: 39877443 PMC: 11769886. DOI: 10.1007/s13340-024-00767-w.


Potential of Fasting C-peptide to Glucose Ratio and Triglyceride Glucose Index as Markers for β-Cell Dysfunction and Insulin Resistance in Patients With Type 2 Diabetes on Insulin Therapy.

Essa B, Meena M Cureus. 2024; 16(8):e66543.

PMID: 39252700 PMC: 11381477. DOI: 10.7759/cureus.66543.


Effects of dulaglutide and trelagliptin on beta-cell function in patients with type 2 diabetes: a randomized controlled study: DUET-beta study.

Kondo Y, Satoh S, Terauchi Y Diabetol Int. 2024; 15(3):474-482.

PMID: 39101164 PMC: 11291836. DOI: 10.1007/s13340-024-00717-6.


Postprandial fatty acid-binding protein 4 is associated with muscle insulin resistance.

Okura T, Ito Y, Anno M, Endo S, Kitao S, Nakamura R Diabetologia. 2024; 67(10):2304-2315.

PMID: 39060707 DOI: 10.1007/s00125-024-06222-4.


Efficacy and safety of oral semaglutide in older patients with type 2 diabetes: a retrospective observational study (the OTARU-SEMA study).

Oe Y, Nomoto H, Cho K, Yokozeki K, Ono T, Miya A BMC Endocr Disord. 2024; 24(1):124.

PMID: 39049060 PMC: 11267784. DOI: 10.1186/s12902-024-01658-6.


References
1.
Albareda M, Rigla M, Rodriguez-Espinosa J, Caballero A, Chico A, Cabezas R . Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes. Diabetes Res Clin Pract. 2005; 68(3):202-6. DOI: 10.1016/j.diabres.2004.10.005. View

2.
Meier J, Menge B, Breuer T, Muller C, Tannapfel A, Uhl W . Functional assessment of pancreatic beta-cell area in humans. Diabetes. 2009; 58(7):1595-603. PMC: 2699865. DOI: 10.2337/db08-1611. View

3.
Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S . Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia. 2002; 45(1):85-96. DOI: 10.1007/s125-002-8248-z. View

4.
Franz M, Monk A, Barry B, McClain K, Weaver T, Cooper N . Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. J Am Diet Assoc. 1995; 95(9):1009-17. DOI: 10.1016/S0002-8223(95)00276-6. View

5.
Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E . Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 2014; 1(5):212-28. PMC: 4020724. DOI: 10.1111/j.2040-1124.2010.00074.x. View